SCHEMBL5401249

SCHEMBL5401249

[NH]C(=O)CSc1nc2ccccc2s1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.77
APEX1 P27695 1/20 0.77
RECQL P46063 1/20 0.77
MAPT P10636 3/20 0.73
ALOX5 P09917 1/20 0.66
CYP1A2 P05177 3/20 0.63
MAPK1 P28482 3/20 0.63
CYP2D6 P10635 2/20 0.63
CYP3A4 P08684 2/20 0.63
CYP2C19 P33261 2/20 0.63
HIF1A Q16665 1/20 0.63
L3MBTL1 Q9Y468 1/20 0.63
ALDH1A1 P00352 5/20 0.63
HPGD P15428 4/20 0.63
SMN1; SMN2 Q16637 4/20 0.62
HSD17B10 Q99714 3/20 0.62
TSHR P16473 1/20 0.62
NPC1 O15118 4/20 0.61
RAB9A P51151 3/20 0.61
PKM P14618 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1286369 0.86 POLB (0.79) POLBAPEX1RECQLMAPTALOX5
SCHEMBL13629728 0.84 MAPT (1.00) POLBAPEX1RECQLMAPTALOX5
SCHEMBL2261407 0.84 POLB (0.77) POLBAPEX1RECQLMAPTALOX5
SCHEMBL10759553 0.83 POLB (0.75) POLBAPEX1RECQLMAPTALOX5
SCHEMBL10404194 0.82 POLB (0.73) POLBAPEX1RECQLMAPTALOX5
SCHEMBL13461102 0.82 POLB (0.83) POLBAPEX1RECQLMAPTALOX5
SCHEMBL10404196 0.82 POLB (0.73) POLBAPEX1RECQLMAPTALOX5
SCHEMBL10759434 0.81 ALDH1A1 (0.74) POLBAPEX1RECQLMAPTALOX5
SCHEMBL10404168 0.81 POLB (0.71) POLBAPEX1RECQLMAPTALOX5
SCHEMBL10404170 0.81 POLB (0.71) POLBAPEX1RECQLMAPTALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070066614-A1 Ihibitors of 11-beta-hydroxy steroid dehydrogenase type 1 BIOVITRUM AB 2007-03-22 US claimed
US-7173030-B2 Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1 BIOVITRUM AB (SE) 2007-02-06 US claimed
EP-1631558-A1 INHIBITORS OF 11-BETA-HYDROXY STEROID DEHYDROGENASE TYPE I BIOVITRUM AB (SE) 2006-03-08 EP claimed
US-20050009821-A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 BIOVITRUM AB 2005-01-13 US claimed
WO-2004103980-A1 INHIBITORS OF 11-BETA-HYDROXY STEROID DEHYDROGENASE TYPE I BIOVITRUM AB (SE) 2004-12-02 WO claimed
US-20070066614-A1 Ihibitors of 11-beta-hydroxy steroid dehydrogenase type 1 BIOVITRUM AB 2007-03-22 US disclosed
US-7173030-B2 Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1 BIOVITRUM AB (SE) 2007-02-06 US disclosed
US-20050009821-A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 BIOVITRUM AB 2005-01-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050009821-A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 HSD11B1, HSD17B1, HSD11B2 POLB 615/4885APEX1 1418/4885RECQL 1071/4885
US-20070066614-A1 Ihibitors of 11-beta-hydroxy steroid dehydrogenase type 1 HSD11B1, HSD17B1, HSD17B11 POLB 932/4885APEX1 2747/4885RECQL 1173/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.